Criterios de diagnóstico y tratamiento | 20 OCT 14

Deterioro cognitivo y demencia leve

Los médicos de atención primaria son el primer punto de contacto para la mayoría de los pacientes con estos trastornos por lo que deben estar familiarizados con el diagnóstico, el pronóstico y la gestión.
Autor/a: David S. Knopman, MDemail, Ronald C. Petersen, PhD, MD Mild Cognitive Impairment and Mild Dementia: A Clinical Perspective
INDICE:  1. Desarrollo | 2. Referencias
  1. Plassman, B.L., Langa, K.M., Fisher, G.G. et al. Prevalence of dementia in the United States: the Aging, Demographics, and Memory Study. Neuroepidemiology. 2007; 29: 125–132
  2. Petersen, R.C., Roberts, R.O., Knopman, D.S. et al. Prevalence of mild cognitive impairment is higher in men: the Mayo Clinic Study of Aging. Neurology. 2010; 75: 889–897
  3. Knopman, D.S., Petersen, R.C., Rocca, W.A., Larson, E.B., and Ganguli, M. Passive case-finding for Alzheimer's disease and dementia in two U.S. communities. Alzheimers Dement. 2011; 7: 53–60
  4. Petersen, R.C. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004; 256: 183–194
  5. Albert, M.S., DeKosky, S.T., Dickson, D. et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7: 270–279
  6. McKhann, G.M., Knopman, D.S., Chertkow, H. et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011; 7: 263–269
  7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. American Psychiatric Association, Washington, DC; 2013
  8. Petersen, R.C. Clinical practice: mild cognitive impairment. N Engl J Med. 2011; 364: 2227–2234
  9. Roberts, R.O., Knopman, D.S., Mielke, M.M. et al. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology. 2014; 82: 317–325
  10. Koepsell, T.D. and Monsell, S.E. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology. 2012; 79: 1591–1598
  11. Lopez, O.L., Becker, J.T., Chang, Y.F. et al. Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study. Neurology. 2012; 79: 1599–1606
  12. Galasko, D., Edland, S.D., Morris, J.C., Clark, C., Mohs, R., and Koss, E. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part XI: clinical milestones in patients with Alzheimer's disease followed over 3 years. Neurology. 1995; 45: 1451–1455
  13. Petersen, R.C., Aisen, P.S., Beckett, L.A. et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010; 74: 201–209
  14. Amariglio, R.E., Townsend, M.K., Grodstein, F., Sperling, R.A., and Rentz, D.M. Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc. 2011; 59: 1612–1617
  15. Manly, J.J., Tang, M.X., Schupf, N., Stern, Y., Vonsattel, J.P., and Mayeux, R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol. 2008; 63: 494–506
  16. Jessen, F., Wiese, B., Bachmann, C...., and German Study on Aging, Cognition and Dementia in Primary Care Patients Study Group. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry. 2010; 67: 414–422
  17. Pfeffer, R.I., Kurosaki, T.T., Harrah, C.H. Jr., Chance, J.M., and Filos, S. Measurement of functional activities in older adults in the community. J Gerontol. 1982; 37: 323–329
  18. Teng, E., Becker, B.W., Woo, E., Knopman, D.S., Cummings, J.L., and Lu, P.H. Utility of the Functional Activities Questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Dis Assoc Disord. 2010; 24: 348–353
  19. United States Agency for Health Care Policy and Research. Early Identification of Alzheimer’s Disease and Related Dementias. US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Rockville, MD; 1996 (Clinical Practice Guideline 19)
  20. Nasreddine, Z.S., Phillips, N.A., Bédirian, V. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53: 695–699
  21. Rossetti, H.C., Lacritz, L.H., Cullum, C.M., and Weiner, M.F. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology. 2011; 77: 1272–1275


Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024